LHC Group, Inc. (NASDAQ:LHCG) COO Donald Dwayne Stelly sold 14,216 shares of the firm’s stock in a transaction on Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total value of $909,824.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
NASDAQ:LHCG traded up $0.65 during mid-day trading on Friday, reaching $71.31. 298,050 shares of the stock were exchanged, compared to its average volume of 344,820. The firm has a market cap of $1,303.90, a P/E ratio of 29.47, a PEG ratio of 1.15 and a beta of 0.70. LHC Group, Inc. has a 1-year low of $51.38 and a 1-year high of $76.14. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.28.
LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, February 28th. The health services provider reported $0.62 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.62. The firm had revenue of $292.40 million for the quarter, compared to analyst estimates of $280.82 million. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. LHC Group’s revenue was up 24.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.58 earnings per share. sell-side analysts expect that LHC Group, Inc. will post 3.5 EPS for the current year.
A number of research firms have issued reports on LHCG. BidaskClub upgraded LHC Group from a “sell” rating to a “hold” rating in a research note on Wednesday. Zacks Investment Research raised LHC Group from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. Stephens set a $74.00 price target on LHC Group and gave the company a “buy” rating in a report on Friday, March 2nd. Craig Hallum raised their price target on LHC Group from $70.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Jefferies Group reissued a “buy” rating and set a $84.00 price target on shares of LHC Group in a report on Wednesday. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $76.80.
A number of large investors have recently added to or reduced their stakes in LHCG. Renaissance Technologies LLC grew its holdings in LHC Group by 1,862.8% during the fourth quarter. Renaissance Technologies LLC now owns 184,500 shares of the health services provider’s stock worth $11,301,000 after acquiring an additional 175,100 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its holdings in LHC Group by 558.3% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 200,000 shares of the health services provider’s stock worth $12,250,000 after acquiring an additional 169,620 shares during the period. Deutsche Bank AG grew its holdings in LHC Group by 371.5% during the fourth quarter. Deutsche Bank AG now owns 148,880 shares of the health services provider’s stock worth $9,117,000 after acquiring an additional 117,301 shares during the period. Allianz Asset Management GmbH grew its holdings in LHC Group by 148.2% during the fourth quarter. Allianz Asset Management GmbH now owns 125,263 shares of the health services provider’s stock worth $7,673,000 after acquiring an additional 74,793 shares during the period. Finally, Gilder Gagnon Howe & Co. LLC grew its holdings in LHC Group by 231.9% during the third quarter. Gilder Gagnon Howe & Co. LLC now owns 96,017 shares of the health services provider’s stock worth $6,810,000 after acquiring an additional 67,089 shares during the period. 89.87% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This news story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/04/08/lhc-group-inc-lhcg-coo-sells-909824-00-in-stock.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.